Glucagon-like peptide-1 gene therapy

Experimental Diabetes Research

Volumn 2011, Issue , 2011, Pages

  Rowzee, Anne M ^a   Cawley, Niamh X ^b   Chiorini, John A ^a   Di Pasquale, Giovanni ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV INHIBITOR; EXENDIN 4; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; INSULIN; LIRAGLUTIDE; SITAGLIPTIN; VIRUS VECTOR; PEPTIDE; VENOM;

ADJUVANT THERAPY; ARTICLE; CLINICAL RESEARCH; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; GLUCOSE BLOOD LEVEL; HORMONE ACTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PLASMID; PRIORITY JOURNAL; SALIVARY GLAND; TARGET ORGAN; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; ANIMAL; ANTIBODY SPECIFICITY; GENE THERAPY; GENE TRANSFER; GENETICS; METABOLISM; METHODOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; DIABETES MELLITUS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GLUCAGON-LIKE PEPTIDE 1; HUMANS; ORGAN SPECIFICITY; PEPTIDES; SALIVARY GLANDS; VENOMS;

EID: 80052768816     PISSN: 16875214     EISSN: 16875303     Source Type: Journal    
DOI: 10.1155/2011/601047     Document Type: Article

References (55)

1. Unger R. H., Ohneda A., Valverde I., Eisentraut A. M., Exton J., Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose Journal of Clinical Investigation 1968 47 1 48 65
2. Holst J. J., The physiology of glucagon-like peptide 1 Physiological Reviews 2007 87 4 1409 1439 (Pubitemid 350041474)
3. Riedel M. J., Kieffer T. J., Treatment of diabetes with glucagon-like peptide-1 gene therapy Expert Opinion on Biological Therapy 2010 10 12 1681 1692
4. Brubaker P. L., Minireview: update on incretin biology: focus on glucagon-like peptide-1 Endocrinology 2010 151 5 1984 1989
5. Unger R. H., Ketterer H., Eisentraut A. M., Distribution of immunoassayable glucagon in gastrointestinal tissues Metabolism 1966 15 10 865 867
6. Novak U., Wilks A., Buell G., McEwen S., Idential mRNA for preproglucagon in pancreas and gut European Journal of Biochemistry 1987 164 3 553 558 (Pubitemid 17072809)
7. Rouillé Y., Bianchi M., Irminger J. C., Halban P. A., Role of the prohormone convertase PC2 in the processing of proglucagon to glucagon FEBS Letters 1997 413 1 119 123 (Pubitemid 27348648)
8. Rouillé Y., Kantengwa S., Irminger J. C., Halban P. A., Role of the prohormone convertase PC3 in the processing of proglucagon to glucagon-like peptide 1 Journal of Biological Chemistry 1997 272 52 32810 32816 (Pubitemid 28023615)
9. Scopsi L., Gullo M., Rilke F., Martin S., Steiner D. F., Proprotein convertases (PC1/PC3 and PC2) in normal and neoplastic human tissues: their use as markers of neuroendocrine differentiation Journal of Clinical Endocrinology and Metabolism 1995 80 1 294 301
10. Furuta M., Zhou AN., Webb G., Carroll R., Ravazzola M., Orci L., Steiner D. F., Severe defect in proglucagon processing in islet A-cells of prohormone convertase 2 null mice Journal of Biological Chemistry 2001 276 29 27197 27202
11. Holst J. J., Bersani M., Johnsen A. H., Kofod H., Hartmann B., rskov C., Proglucagon processing in porcine and human pancreas Journal of Biological Chemistry 1994 269 29 18827 18833 (Pubitemid 24226193)
12. Webb G. C., Dey A., Wang J., Stein J., Milewski M., Steiner D. F., Altered proglucagon processing in an -cell line derived from prohormone convertase 2 null mouse islets Journal of Biological Chemistry 2004 279 30 31068 31075 (Pubitemid 39037767)
13. Mojsov S., Heinrich G., Wilson I. B., Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing Journal of Biological Chemistry 1986 261 25 11880 11889 (Pubitemid 17206117)
14. Orskov C., Holst J. J., Knuhtsen S., Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas Endocrinology 1986 119 4 1467 1475 (Pubitemid 17170509)
15. Ugleholdt R., Zhu X., Deacon C. F., rskov C., Steiner D. F., Holst J. J., Impaired intestinal proglucagon processing in mice lacking prohormone convertase 1 Endocrinology 2004 145 3 1349 1355 (Pubitemid 38281019)
16. Suzuki S., Kawai K., Ohashi S., Mukai H., Yamashita K., Comparison of the effects of various C-terminal and N-terminal fragment peptides of glucagon-like peptide-1 on insulin and glucagon release from the isolated perfused rat pancreas Endocrinology 1989 125 6 3109 3114 (Pubitemid 20010691)
17. Orskov C., Wettergren A., Holst J. J., Biological effects and metabolic rates of glucagonlike peptide-1 7-36 amide and glucagonlike peptide-1 7-37 in healthy subjects are indistinguishable Diabetes 1993 42 5 658 661 (Pubitemid 23127154)
18. Friis-Hansen L., Lacourse K. A., Samuelson L. C., Holst J. J., Attenuated processing of proglucagon and glucagon-like peptide-1 in carboxypeptidase E-deficient mice Journal of Endocrinology 2001 169 3 595 602 (Pubitemid 32536993)
19. Garmendia O., Rodrguez M. P., Burrell M. A., Villaro A. C., Immunocytochemical finding of the amidating enzymes in mouse pancreatic A-, B-, and D-cells: a comparison with human and rat Journal of Histochemistry and Cytochemistry 2002 50 10 1401 1415 (Pubitemid 35191484)
20. Jang H. J., Kokrashvili Z., Theodorakis M. J., Carlson O. D., Kim B. J., Zhou J., Hyeon HO. K., Xu X., Chan S. L., Juhaszova M., Bernier M., Mosinger B., Margolskee R. F., Egan J. M., Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1 Proceedings of the National Academy of Sciences of the United States of America 2007 104 38 15069 15074 (Pubitemid 47619594)
21. Elliott R. M., Morgan L. M., Tredger J. A., Deacon S., Wright J., Marks V., Glucagon-like peptide-1(7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns Journal of Endocrinology 1993 138 1 159 166 (Pubitemid 23266831)
22. Reimer R. A., Meat hydrolysate and essential amino acid-induced glucagon-like peptide-1 secretion, in the human NCI-H716 enteroendocrine cell line, is regulated by extracellular signal-regulated kinase1/2 and p38 mitogen-activated protein kinases Journal of Endocrinology 2006 191 1 159 170 (Pubitemid 44756518)
23. Le Nevé B., Daniel H., Selected tetrapeptides lead to a GLP-1 release from the human enteroendocrine cell line NCI-H716 Regulatory Peptides 2011 167 1 14 20
24. Brubaker P. L., Anini Y., Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2 Canadian Journal of Physiology and Pharmacology 2003 81 11 1005 1012 (Pubitemid 38045829)
25. Anini Y., Brubaker P. L., Muscarinic receptors control glucagon-like peptide 1 secretion by human endocrine L cells Endocrinology 2003 144 7 3244 3250 (Pubitemid 36819927)
26. Hansen L., Deacon C. F., rskov C., Holst J. J., Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine Endocrinology 1999 140 11 5356 5363
27. Buteau J., GLP-1 receptor signaling: effects on pancreatic beta-cell proliferation and survival Diabetes Metabolism 2008 34 supplement 2 S73 S77 (Pubitemid 351978286)
28. Chang A. M., The GLP-1 derivative NN2211 restores beta-cell sensitivity to glucose in type 2 diabetic patients after a single dose Diabetes 2003 52 7 1786 1791 (Pubitemid 36792471)
29. Sandhu H., Wiesenthal S. R., MacDonald P. E., McCall R. H., Tchipashvili V., Rashid S., Satkunarajah M., Irwin D. M., Shi Z. Q., Brubaker P. L., Wheeler M. B., Vranic M., Efendic S., Giacca A., Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs Diabetes 1999 48 5 1045 1053 (Pubitemid 29226351)
30. Imeryz N., Yeen B.., Bozkurt A., Cokun T., Villanueva-Penacarrillo M. L., Ulusoy N. B., Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms American Journal of Physiology 1997 273 4 Pt 1 G920 G927
31. Turton M. D., O'Shea D., Gunn I., Beak S. A., Edwards C. M. B., Meeran K., Choi S. J., Taylor G. M., Heath M. M., Lambert P. D., Wilding J. P. H., Smith D. M., Ghatei M. A., Herbert J., Bloom S. R., A role for glucagon-like peptide-1 in the central regulation of feeding Nature 1996 379 6560 69 72 (Pubitemid 26008136)
32. Furman B. L., The development of Byetta (exenatide) from the venom of the Gila monster as an anti-diabetic agent. Toxicon. In press
33. Kolterman O. G., Kim D. D., Shen L., Ruggles J. A., Nielsen L. L., Fineman M. S., Baron A. D., Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus American Journal of Health-System Pharmacy 2005 62 2 173 181 (Pubitemid 40674548)
34. Eng J., Kleinman W. A., Singh L., Singh G., Raufman J. P., Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas Journal of Biological Chemistry 1992 267 11 7402 7405
35. Goke R., Fehmann H. C., Linn T., Schmidt H., Krause M., Eng J., Goke B., Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin- secreting -cells Journal of Biological Chemistry 1993 268 26 19650 19655 (Pubitemid 23270754)
36. Liu M. J., Han J., Lee Y. S., Park MI. S., Shin S., Jun H. S., Amelioration of hyperglycemia by intestinal overexpression of glucagon-like peptide-1 in mice Journal of Molecular Medicine 2010 88 4 351 358
37. Oh S., Lee M., Ko K. S., Choi S., Kim S. W., GLP-1 gene delivery for the treatment of type 2 diabetes Molecular Therapy 2003 7 4 478 483 (Pubitemid 36553416)
38. Choi S., Oh S., Lee M., Kim S. W., Glucagon-like peptide-1 plasmid construction and delivery for the treatment of type 2 diabetes Molecular Therapy 2005 12 5 885 891 (Pubitemid 41614484)
39. Liu M. J., Shin S., Li NA., Shigihara T., Lee Y. S., Yoon JI. W., Jun H. S., Prolonged remission of diabetes by regeneration of cells in diabetic mice treated with recombinant adenoviral vector expressing glucagon-like peptide-1 Molecular Therapy 2007 15 1 86 93 (Pubitemid 46043653)
40. Lee Y. S., Shin S., Shigihara T., Hahm E., Liu M. J., Han J., Yoon JI. W., Jun H. S., Glucagon-like peptide-1 gene therapy in obese diabetic mice results in long-term cure of diabetes by improving insulin sensitivity and reducing hepatic gluconeogenesis Diabetes 2007 56 6 1671 1679 (Pubitemid 46842602)
41. Parsons G. B., Souza D. W., Wu H., Yu D., Wadsworth S. G., Gregory R. J., Armentano D., Ectopic expression of glucagon-like peptide 1 for gene therapy of type II diabetes Gene Therapy 2007 14 1 38 48 (Pubitemid 44942864)
42. Lee Y., Kwon MI. K., Kang E. S., Park Y. M., Choi S. H., Ahn C. W., Kim K. S., Park C. W., Cha B. S., Kim S. W., Sung JE. K., Lee E. J., Lee H. C., Adenoviral vector-mediated glucagon-like peptide 1 gene therapy improves glucose homeostasis in Zucker diabetic fatty rats Journal of Gene Medicine 2008 10 3 260 268 (Pubitemid 351359638)
43. Riedel M. J., Gaddy D. F., Asadi A., Robbins P. D., Kieffer T. J., DsAAV8-mediated expression of glucagon-like peptide-1 in pancreatic beta-cells ameliorates streptozotocin-induced diabetes Gene Therapy 2010 17 2 171 180
44. Gaddy D. F., In vivo expression of HGF/NK1 and GLP-1 From dsAAV vectors enhances pancreatic ss-cell proliferation and improves pathology in the db/db mouse model of diabetes Diabetes 2010 59 12 3108 3116
45. Samson S. L., Gonzalez E. V., Yechoor V., Bajaj M., Oka K., Chan L., Gene therapy for diabetes: metabolic effects of helper-dependent adenoviral exendin 4 expression in a diet-induced obesity mouse model Molecular Therapy 2008 16 11 1805 1812
46. Soltani N., Kumar M., Glinka Y., Prud'Homme G. J., Wang Q., In vivo expression of GLP-1/IgG-Fc fusion protein enhances beta-cell mass and protects against streptozotocin-induced diabetes Gene Therapy 2007 14 12 981 988 (Pubitemid 46865509)
47. Kumar M., Hunag Y., Glinka Y., Prud'Homme G. J., Wang Q., Gene therapy of diabetes using a novel GLP-1/IgG1-Fc fusion construct normalizes glucose levels in db/db mice Gene Therapy 2007 14 2 162 172 (Pubitemid 46043821)
48. Liu R., Li Y., Hu R., Jin T., Deng S., Liang W., Zhang N., Chen J., Prud'homme G. J., Jia W. W., Ma D., Wang Q., A site-specific genomic integration strategy for sustained expression of glucagon-like peptide-1 in mouse muscle for controlling energy homeostasis Biochemical and Biophysical Research Communications 2010 403 2 172 177
49. Perez P., Rowzee A. M., Zheng C., Adriaansen J., Baum B. J., Salivary epithelial cells: an unassuming target site for gene therapeutics International Journal of Biochemistry and Cell Biology 2010 42 6 773 777
50. Cotrim A. P., Mineshiba F., Sugito T., Samuni Y., Baum B. J., Salivary gland gene therapy Dental Clinics of North America 2006 50 2 157 173 (Pubitemid 43356536)
51. Passineau M. J., Alpha-galactosidase a expressed in the salivary glands partially corrects organ biochemical deficits in the fabry mouse through endocrine trafficking Human Gene Therapy 2011 22 3 293 301
52. Adriaansen J., Perez P., Zheng C., Collins M. T., Baum B. J., Human parathyroid hormone is secreted primarily into the bloodstream after rat parotid gland gene transfer Human Gene Therapy 2011 22 1 84 92
53. He X., Goldsmith C. M., Marmary Y., Wellner R. B., Parlow A. F., Nieman L. K., Baum B. J., Systemic action of human growth hormone following adenovirus-mediated gene transfer to rat submandibular glands Gene Therapy 1998 5 4 537 541 (Pubitemid 28200647)
54. Voutetakis A., Cotrim A. P., Rowzee A., Zheng C., Rathod T., Yanik T., Loh Y. P., Baum B. J., Cawley N. X., Systemic delivery of bioactive glucagon-like peptide 1 after adenoviral-mediated gene transfer in the murine salivary gland Endocrinology 2010 151 9 4566 4572
55. Baum B. J., Adriaansen J., Cotrim A. P., Goldsmith C. M., Perez P., Qi S., Rowzee A. M., Zheng C., Gene therapy of salivary diseases Methods in Molecular Biology 2010 666 3 20